,Gene,Gene synonym,Ensembl,Gene description,Chromosome,Position,Protein class,Evidence,Antibody,Reliability (IH),Reliability (Mouse Brain),Reliability (IF),Subcellular location,Prognostic p-value,RNA cancer category,RNA tissue category,RNA TS,RNA TS TPM,TPM max in non-specific,RNA cell line category,RNA CS,RNA CS TPM
0,MMP26,"endometase, MGC126590, MGC126592",ENSG00000167346,Matrix metallopeptidase 26,11,4704927-4992429,"Enzymes, FDA approved drug targets, Predicted secreted proteins",Evidence at transcript level,,,,,,,Group enriched,Tissue enriched,63,endometrium: 23.9,"prostate,testis: 0.3",Not detected,,
1,MMP10,STMY2,ENSG00000166670,Matrix metallopeptidase 10,11,102770503-102780628,"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins",Evidence at protein level,CAB002159,Uncertain,,Approved,Plasma membrane<br>Cytosol,Urothelial cancer:7.12e-4 (favourable),Tissue enhanced,Tissue enriched,40,endometrium: 443.1,appendix: 11.1,Cell line enhanced,,BJ: 10.0;HUVEC TERT2: 12.6;SCLC-21H: 5.6
2,PAEP,"GD, GdA, GdF, GdS, MGC138509, MGC142288, PAEG, PEP, PP14",ENSG00000122133,Progestagen associated endometrial protein,9,135561756-135566955,"Predicted intracellular proteins, Predicted secreted proteins",Evidence at protein level,"CAB016762, HPA020108, HPA029473",Enhanced,,,,"Renal cancer:0.00e+0 (unfavourable), Liver cancer:6.61e-6 (unfavourable), Stomach cancer:5.46e-4 (unfavourable)",Tissue enriched,Tissue enriched,7,endometrium: 437.0,seminal vesicle: 61.5,Cell line enriched,6.0,SK-MEL-30: 16.7
3,IL17C,"CX2, IL-17C, IL-21, MGC126884, MGC138401",ENSG00000124391,Interleukin 17C,16,88638591-88640473,Predicted secreted proteins,Evidence at protein level,HPA065051,Supported,,,,,Mixed,Tissue enriched,6,endometrium: 3.5,gallbladder: 0.6,Not detected,,
